Seiji Tanaka

Seiji Tanaka

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2006 in Nature
Verified
Journal Article
Closed access
PDF file
STSeiji Tanaka
Seiji Tanaka
TUToshiko Umemori
Toshiko Umemori
KHKazuyuki Hirai
Kazuyuki Hirai
SMSachiko Muramatsu
Sachiko Muramatsu
YKYoichiro Kamimura
Yoichiro Kamimura
HAHiroyuki Araki
Hiroyuki Araki

19 December 2005 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
Yoshikazu OhyaYoshikazu Ohya
Yoshikazu Ohya
JSJun Sese
Jun Sese
MYMasashi Yukawa
Masashi Yukawa
FSFumi Sano
Fumi Sano
YNYoichiro Nakatani
Yoichiro Nakatani
SMShinichi Morishita
Shinichi Morishita
One of the most powerful techniques for attributing functions to genes in uni- and multicellular organisms is comprehensive analysis of mutant traits. In this study, systematic and quantitative analyses of mutant traits are achieved in the budding yeast Saccharomyces cerevisiae by investigating morphological phenotypes. Analysis of fluorescent microscopic images of triple-stained cells makes it possible to treat morphological variations as quantitative traits. Deletion of nearly half of the yeast genes not essential for growth affects these morphological traits. Similar morphological phenotypes are caused by deletions of functionally related genes, enabling a functional assignment of a locus to a specific cellular pathway. The high-dimensional phenotypic analysis of defined yeast mutant strains provides another step toward attributing gene function to all of the genes in the yeast genome.

1 December 2011 in Current Biology
Verified
Journal Article
Closed access
STSeiji Tanaka
Seiji Tanaka
RNRyuichiro Nakato
Ryuichiro Nakato
YKYuki Katou
Yuki Katou
KSKatsuhiko Shirahige
Katsuhiko Shirahige
HAHiroyuki Araki
Hiroyuki Araki

11 February 2002 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
STSeiji Tanaka
Seiji Tanaka
JDJohn F.X. Diffley
John F.X. Diffley

23 July 2013 in Cold Spring Harbor Perspectives in Biology
Verified
Journal Article
Closed access
PDF file
STSeiji Tanaka
Seiji Tanaka
HAHiroyuki Araki
Hiroyuki Araki
Many replication proteins assemble on the pre-RC-formed replication origins and constitute the pre-initiation complex (pre-IC). This complex formation facilitates the conversion of Mcm2–7 in the pre-RC to an active DNA helicase, the Cdc45–Mcm–GINS (CMG) complex. Two protein kinases, cyclin-dependent kinase (CDK) and Dbf4-dependent kinase (DDK), work to complete the formation of the pre-IC. Each kinase is responsible for a distinct step of the process in yeast; Cdc45 associates with origins in a DDK-dependent manner, whereas the association of GINS with origins depends on CDK. These associations with origins also require specific initiation proteins: Sld3 for Cdc45; and Dpb11, Sld2, and Sld3 for GINS. Functional homologs of these proteins exist in metazoa, although pre-IC formation cannot be separated by requirement of DDK and CDK because of experimental limitations. Once the replicative helicase is activated, the origin DNA is unwound, and bidirectional replication forks are established.

15 October 2002 in Genes & Development
Verified
Journal Article
Closed access
PDF file
STSeiji Tanaka
Seiji Tanaka
JDJohn F.X. Diffley
John F.X. Diffley
Although genomic instability is a hallmark of human cancer cells, the mechanisms by which genomic instability is generated and selected for during oncogenesis remain obscure. In most human cancers, the pathway leading to the activation of the G1 cyclins is deregulated. Using budding yeast as a model, we show that overexpression of the G1 cyclin Cln2 inhibits the assembly of prereplicative complexes (pre-RCs) and induces gross chromosome rearrangements (GCR). Our results suggest that deregulation of G1 cyclins, selected for in oncogenesis because it confers clonal growth advantage, may also provide an important mechanism for generating genomic instability by inhibiting replication licensing.